isobavachin has been researched along with Prostatic Neoplasms in 2 studies
*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borah, P; Browne, RB; Goswami, N; Roy, JD | 1 |
| Huang, S; Luo, H; Ren, L; Shao, C; Zhang, J; Zhao, J | 1 |
2 other study(ies) available for isobavachin and Prostatic Neoplasms
| Article | Year |
|---|---|
Computational approaches for evaluation of isobavachin as potential inhibitor against t877a and w741l mutations in prostate cancer.
Topics: Codon; Flavonoids; Humans; Ligands; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Prostatic Neoplasms; Receptors, Androgen | 2023 |
An integrated in vitro/in silico approach to assess the anti-androgenic potency of isobavachin.
Topics: Androgen Antagonists; Androgens; Flavonoids; Humans; Male; Prostatic Neoplasms | 2023 |